Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 32, Issue 6, 2012, Pages 426-434

  Goldie, Sue J ^a   Levin, Carol ^b   Mosqueira Lovón, N Rocio ^c   Ortendahl, Jesse ^a   Kim, Jane ^a   O'Shea, Meredith ^a   Diaz Sanchez, Mireia ^d   Mendoza Araujo, Maria Ana ^e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b PATH   (United States)

^c INSTITUTO DE INVESTIGACIÓN NUTRICIONAL   (Peru)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e MINISTERIO DE SALUD   (Peru)

Author keywords

Cost effectiveness evaluation; Papillomavirus infections; Papillomavirus vaccines; Peru; Uterine cervical neoplasms; Vaccination

Indexed keywords

CANCER; COST-BENEFIT ANALYSIS; EPIDEMIOLOGY; HEALTH IMPACT; INFECTIOUS DISEASE; NUMERICAL MODEL; VACCINATION; VIRUS; WOMENS HEALTH;

PERU;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84874869518     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892012001400006     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr Accessed August 2010.
2. World Health Organization. Health statistics and health information systems: projections of mortality and burden of disease, 2004-2030 [Internet]. Geneva: WHO; c2009. Available from: http://www.who.int/healthinfo/global-burden- disease/projections/en/ Accessed 9 October 2009.
3. United Nations. World population prospects: the 2006 revision [CD-ROM]. Extended dataset. New York: UN Department of Economic and Social Affairs, Population Division; 2007.
4. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356(19):1915-27.
5. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a doubleblind, randomised study in young women. Lancet. 2009;374(9686):301-14.
6. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26 Suppl 10:K29-41.
7. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158-68.
8. Goldie SJ, Diaz M, Constenla D, Alvis N, Andrus JK, Kim SY. Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Vaccine. 2008;26 Suppl 11:L59-72.
9. Colantonio L, Gómez JA, Demarteau N, Standaert B, Pichón-Rivière A, Augustovski F. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries. Vaccine. 2009;27(40):5519-29.
10. PATH; Instituto de Investigación Nutricional; Ministerio de Salud (PE). Resumen de la experiencia y evaluación del proyecto piloto de la vacuna contra el virus del papiloma humano en el Perú. Seattle: PATH; 2009.
11. Penny ME, Bartolini RM, Mosqueira NR. Evaluation of a one-year HPV vaccine delivery demonstration project in Peru. Lima: Instituto de Investigación Nutricional; 2009.
12. PATH; Instituto de Investigación Nutricional; and Ministerio de Salud, Estrategia Sanitaria Nacional de Inmunizaciones (PE). HPV vaccination in Latin America: lessons learned from a pilot program in Peru. Seattle: PATH; 2010. Available from: http://www.rho.org/files/PATH-HPV-lessons-learned-Peru- 2010.pdf Accessed 9 June 2011.
13. PATH; Instituto de Investigación Nutricional (PE). Shaping a strategy to introduce HPV vaccines in Peru: formative research results from the HPV Vaccines: Evidence for Impact project. Seattle: PATH; 2009. Available from: http://www.rho.org/files/PATH-FRTS-Peru-eng.pdf Accessed 9 October 2009.
14. Penny M, Bartolini R, Mosqueira NR, LaMontagne DS, Mendoza MA, Ramos I, et al. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine. 2011;29(31):5022-30.
15. Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr. 2007; 5(1):11.
16. Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'Shea MK, et al. Cost-effectiveness of HPV 16,18 vaccination in Brazil. Vaccine. 2007;25(33):6257-70.
17. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine. 2008;26(32):4080-93.
18. Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, et al. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol. 2007;166(2):137-50.
19. Kim JJ, Andres-Beck B, Goldie SJ. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer. 2007;97(9): 1322-8.
20. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359(8):821-32.
21. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Vaccine. 2008;26(32):4015-24.
22. Diaz M, Kim JJ, Albero G, de Sanjosé S, Clifford G, Bosch FX, et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer. 2008;99(2):230-8.
23. World Health Organization, Department on Immunization, Vaccines and Biologicals. Immunization coverage cluster survey - reference manual. Geneva: WHO; 2005. (WHO/IVB/04.23). Available from: http://www.who.int/vaccines- documents/DocsPDF05/www767.pdf
24. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middleincome countries. Bull World Health Organ. 2011;89(11):821-30B.
25. GAVI Alliance. GAVI welcomes lower prices for life-saving vaccines [press release]. Geneva: GAVI Alliance; 2011 Jun 6. Available from: http://www.gavialliance.org/library/news/press-releases/2011/ gavi-welcomeslower-prices-for-life-saving-vaccines/Accessed 13 June 2011.
26. World Health Organization, Department on Immunization, Vaccines and Biologicals. Guidelines for estimating costs of introducing vaccines into the national immunization system [Internet]. Geneva: WHO; 2002. (WHO/V&B/02.11). Available from: http://whqlibdoc.who.int/hq/2002/WHO-V&B-02.11.pdf Accessed 1 April 2008.
27. World Health Organization. Immunization financing [Internet]. Geneva: WHO; c2008-2012. Available from: http://www.who.int/immunization-financing/en/ Accessed 16 March 2008.
28. World Bank. World development indicators [Internet]. Washington: World Bank; c2008. Available from: http://data.worldbank.org/data-catalog/world- development-indicators Accessed 24 January 2008.
29. International Labour Office. Women and men in the informal economy: a statistical picture. Geneva: ILO; 2002. Available from: http://www.ilo.org/dyn/ infoecon/docs/441/F596332090/women%20and%20men%20stat%20picture.pdf Accessed 24 October 2005.
30. U.S. Department of Commerce International Trade Association. 1999 income data [Internet]. Washington: ITA; 2005. Available from: http://ia.ita.doc.gov/ wages/99wages/99wages.htm Accessed 24 October 2005.
31. World Health Organization. WHO-CHOICE (CHOosing Interventions that are Cost Effective). Geneva: WHO; 2009. Available from: http://www.who.int/choice/ en/ Accessed 9 October 2009.
32. U.S. Department of Labor Bureau, International Labor Affairs. Wages, benefits, poverty line, and meeting workers' needs in the apparel and footwear industries of selected countries. Washington: ILAB; 2000. Available from: http://www.ssalt.org/pdfs/United%20States/US-DOL-Wages-Benefits-Poverty-Line- and-Meeting-Workers%27-Needs.pdf Accessed 24 October 2005.
33. DCP2.org. Disease Control Priorities Project [homepage on the Internet]. Washington: DCPP; c2009. Available from: http://www.dcp2.org/main/Home.html Accessed 9 October 2009.
34. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. 2nd ed. New York: Oxford University Press; 1997.
35. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
36. World Health Organization. Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health. Geneva: WHO; 2001. Available from: http://whqlibdoc.who.int/ publications/2001/924154550x.pdf
37. Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reprod Health Matters. 2008;16(32):104-12.
38. Kim SY, Salomon JA, Goldie SJ. Economic evaluation of hepatitis B vaccination in lowincome countries: using cost-effectiveness affordability curves. Bull World Health Organ. 2007;85(11):833-42.
39. Franceschi S, Cuzick J, Herrero R, Dillner J, Wheeler CM. EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer. 2009;125(10):2246-55.
40. www.mef.gob.pe. Ministerio de Economía y Finanzas [homepage on the Internet]. Lima: MEF; c2010-2012. Available from: www.mef.gob.pe Accessed 20 December 2010.
41. Vicari A. Peru introduces nationwide HPV vaccination. Global Immunization News [Internet]. Geneva: World Health Organization; 2011 Feb 25. Available from: http://www.who.int/immunization/GIN-February-2011.pdf Accessed 15 June 2011.
42. Levin CE, Ruel MT, Morris SS, Maxwell DG, Armar-Klemesu M, Ahiadeke C. Working women in urban settings: traders, vendors, and food security in Accra. World Dev. 1999;27(11):1977-91.
43. Quisumbing A, Brown L, Feldstein HS, Haddad L, Peña C. Women: the key to food security. Food Policy Report. Washington: International Food Policy Research Institute; 1995. Available from: http://www.ifpri.org/sites/default/ files/publications/fpr21.pdf
44. United Nations Population Fund. Food for the future: women, population, and food security. New York: UNFPA; 1997.